These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 1360236)

  • 1. Tyrosine kinase receptor--nuclear protooncogene interactions in breast cancer.
    Dickson RB; Salomon DS; Lippman ME
    Cancer Treat Res; 1992; 61():249-73. PubMed ID: 1360236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic interaction of transforming growth factor alpha and c-myc in mouse mammary and salivary gland tumorigenesis.
    Amundadottir LT; Johnson MD; Merlino G; Smith GH; Dickson RB
    Cell Growth Differ; 1995 Jun; 6(6):737-48. PubMed ID: 7669729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of EGF receptor protooncogene expression by growth factors and hormones in human breast carcinoma cells.
    Fernandez-Pol JA
    Crit Rev Oncog; 1991; 2(2):173-85. PubMed ID: 1677274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity.
    Muthuswamy SK; Siegel PM; Dankort DL; Webster MA; Muller WJ
    Mol Cell Biol; 1994 Jan; 14(1):735-43. PubMed ID: 7903421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms involving an expanding erbB/EGF receptor family of tyrosine kinases in human neoplasia.
    Di Fiore PP; Kraus MH
    Cancer Treat Res; 1992; 61():139-60. PubMed ID: 1360229
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG; Ethier SP
    Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.
    Guy CT; Webster MA; Schaller M; Parsons TJ; Cardiff RD; Muller WJ
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10578-82. PubMed ID: 1359541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase signalling in breast cancer: tyrosine kinase-mediated signal transduction in transgenic mouse models of human breast cancer.
    Andrechek ER; Muller WJ
    Breast Cancer Res; 2000; 2(3):211-6. PubMed ID: 11250712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-myc, c-Ha-ras1, and c-erbB-2 proto-oncogenes in normal and malignant human breast epithelial cells.
    Benz CC; Scott GK; Santos GF; Smith HS
    J Natl Cancer Inst; 1989 Nov; 81(22):1704-9. PubMed ID: 2572702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
    Machotka SV; Garrett CT; Schwartz AM; Callahan R
    Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
    Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
    Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of TGF-alpha, EGF-R, c-erbB-2, c-H-ras, c-myc, estrogen and progesterone in benign and malignant human breast lesions: a concomitant expression.
    Spaventi R; Kamenjicki E; Pecina N; Grazio S; Grazio S; Pavelic J; Kusic B; Cvrtila D; Danilovic Z; Spaventi S
    In Vivo; 1994; 8(2):183-9. PubMed ID: 7919121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of expression and transforming ability of the c-erbB-2 gene.
    Matsuda S; Akiyama T; Yamada Y; Ishii S; Aizawa S; Mori S; Toyoshima K; Yamamoto T
    Princess Takamatsu Symp; 1989; 20():93-101. PubMed ID: 2577338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of c-erbB-2 and c-myc RNA levels in tamoxifen-treated breast cancer.
    Le Roy X; Escot C; Brouillet JP; Theillet C; Maudelonde T; Simony-Lafontaine J; Pujol H; Rochefort H
    Oncogene; 1991 Mar; 6(3):431-7. PubMed ID: 1707153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells.
    Wilson CA; Cajulis EE; Green JL; Olsen TM; Chung YA; Damore MA; Dering J; Calzone FJ; Slamon DJ
    Breast Cancer Res; 2005; 7(6):R1058-79. PubMed ID: 16457687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.